Operose Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$832 Hold
13
﹤0.01% 492
2026
Q1
$926 Hold
13
﹤0.01% 544
2025
Q4
$1.07K Sell
13
-13
-50% -$1.01K ﹤0.01% 449
2025
Q3
$1.95K Buy
26
+5
+24% +$373 ﹤0.01% 409
2025
Q2
$1.55K Buy
21
+13
+163% +$905 ﹤0.01% 383
2025
Q1
$646 Hold
8
﹤0.01% 370
2024
Q4
$625 Sell
8
-119
-94% -$10.1K ﹤0.01% 414
2024
Q3
$11.9K Hold
127
﹤0.01% 473
2024
Q2
$9.9K Hold
127
﹤0.01% 449
2024
Q1
$11.5K Buy
127
+4
+3% +$333 ﹤0.01% 467
2023
Q4
$9.51K Sell
123
-524
-81% -$36.7K ﹤0.01% 473
2023
Q3
$44K Buy
647
+351
+119% +$25.5K 0.02% 330
2023
Q2
$24K Buy
296
+48
+19% +$3.83K 0.01% 217
2023
Q1
$20.3K Buy
+248
New +$17.7K 0.01% 222

Other funds holding GEHC

Operose Advisors's GEHC Position: Q2 2026 in Review

Operose Advisors held its GE HealthCare (GEHC) position steady in Q2 2026 at 13 shares worth $832. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Operose Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $44K in Q3 2023. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Operose Advisors held 13 shares of GE HealthCare worth $832 as of Q2 2026.
  • Operose Advisors left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Operose Advisors's portfolio in Q2 2026, its #492 holding.
  • Operose Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Operose Advisors's GE HealthCare position peaked at $44K in Q3 2023.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.